Canada’s main stock index sunk lower on Tuesday, weighed down by the energy sector leading a broad decline. Traders have been holding off on any major moves amid broader uncertainty around a US debt deal.


Sponsored by
Protecting Those Who Protect Us


Back from the Memorial Day holiday, US markets were mixed and the S&P 500 dipped after the Biden administration and Republican lawmakers reached a tentative deal on raising the debt ceiling. President Biden and House Majority Leader McCarthy reached an agreement to avoid a default over the weekend and Congress set to vote on the legislation as soon as Wednesday.

TSX19,739.70-228.25TSX
TSXV596.96-9.89TSXV
CSE164.35+2.63TSXV
DJIA33,042.78-50.56DJIA
NASDAQ13,017.43+41.74NASDAQ
S&P 5004,203.65-1.80S&P 500

The Canadian dollar traded for 73.51 cents US, compared to 73.56 cents US on Monday.

US crude futures traded $2.98 lower at $69.69 a barrel, and the Brent contract lost $3.24 to $73.83 a barrel.

The price of gold was up US$16.75 to US$ 1,958.52.

In world markets, the Nikkei was up 94.62 points to 31,328.16, the Hang Seng was up 44.67 points to 18,595.78, the FTSE was down 110.43 points to 7,516.77, and the DAX was down 43.82 points to 15,908.91.

The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, click here.

More From The Market Online

Unsung profits: Three money-making penny stocks trading for cheap

To make money in stocks, you need to develop a strong sense for the irrational, a quality often found among cheaply priced penny stocks.
Pinnacle Silver and Gold - Shot from Pinnacle Silver and Gold's Argosy Gold Project in Ontario.

This junior gold stock is at an all-time low and ready to rally

Junior gold investors currently enjoy dozens of opportunities with multi-bagger upside with stocks at or near all-time lows.
stock market down

@ the Bell: TSX hits near-month high

The TSX rose near highs not seen in a month, but a split between indices capped gains as mining and energy were the only…

FSD Pharma submits MS treatment clinical trial for review in Australia

FSD Pharma (CSE:HUGE) submits its MS treatment's Phase-1 Multiple Ascending Doses Clinical Trial Application for ethics review in Australia.